Apolipoprotein E, amyloid, and Alzheimer disease.

Mol Interv

Neuroscience Discovery Research, Lilly Research Laboratories Indianapolis, IN 46285, USA.

Published: October 2002

Despite important inroads into the molecular pathology of Alzheimer disease, effective long-term treatment for the condition remains elusive. Among the many gene products that are recognized as factors in the disease is apolipoprotein ( (apoE). The risk that specific isoforms of apoE pose with regard to Alzheimer Disease clearly varies, and so the roles that apoE plays in the brain will be crucial to a full understanding of the disease and to efforts to develop effective therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1124/mi.2.6.363DOI Listing

Publication Analysis

Top Keywords

alzheimer disease
12
disease
5
apolipoprotein amyloid
4
amyloid alzheimer
4
disease despite
4
despite inroads
4
inroads molecular
4
molecular pathology
4
pathology alzheimer
4
disease effective
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!